Mandeep Chawla, Chief Financial Officer at CELESTICA INC (CLS), sold 17,000 shares at $394.25 ($6.8M) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($6.8M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $394.25 | 200 | $79K | 1.2% |
| 2 | $395.41 | 212 | $84K | 1.2% |
| 3 | $396.24 | 848 | $336K | 4.9% |
| 4 | $397.32 | 1,661 | $660K | 9.7% |
| 5 | $398.29 | 3,788 | $1.5M | 22.2% |
| 6 | $399.22 | 3,607 |
| $1.4M |
| 21.2% |
| 7 | $400.20 | 1,240 | $496K | 7.3% |
| 8 | $401.30 | 1,508 | $605K | 8.9% |
| 9 | $402.21 | 2,919 | $1.2M | 17.3% |
| 10 | $402.93 | 697 | $281K | 4.1% |
| 11 | $403.79 | 40 | $16K | 0.2% |
| 12 | $405.77 | 40 | $16K | 0.2% |
| 13 | $406.82 | 120 | $49K | 0.7% |
| 14 | $408.88 | 80 | $33K | 0.5% |
| 15 | $412.99 | 40 | $17K | 0.2% |
| Total | $399.65 avg | 17,000 | $6.8M | 100% |
| Filing → |
| CLS | SELL | 2025-02-05 | $22.2M | — | Filing → |
| CLS | SELL | 2025-02-03 | $2.4M | — | Filing → |